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1  | INTRODUC TION
During the last EFP-AAP World Workshop, peri-implantitis has 
been defined as an infective pathologic condition affecting a 
previously installed dental implant, characterized by increased 
probing depth with concomitant bleeding and/or suppura-
tion besides peri-implant bone loss (Schwarz, Derks, Monje, 
& Wang, 2018). Its high prevalence has been extensively 
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Objectives: To evaluate the 10-year outcomes of a regenerative surgical treatment 
of single peri-implantitis intrabony defects, by means of deproteinized bovine bone 
mineral with 10% collagen (DBBMC).
Material and Methods: The original population consisted of 26 patients with one 
crater-like defect, around either SLA or TPS dental implants, with a probing depth 
≥6 mm and no implant mobility. After debridement and surface decontamination, the 
defects were filled with DBBMC. Subsequently, patients were placed in an individu-
alized supportive peri-implant/periodontal therapy (SPT) program.
Results: Fourteen patients (eight SLA and six TPS) reached the 10-year examina-
tion. The overall implant survival rate was 67%, 80% for the SLA, and 55% for the 
TPS implants. During SPT, five patients were lost to follow-up, eight patients needed 
additional antibiotic and/or surgical therapy, and seven patients had the implant re-
moved. PD was reduced from 6.6 ± 1.3 to 3.2 ± 0.7 mm in SLA and from 7.2 ± 1.5 
to 3.4 ± 0.6 mm in TPS. BOP decreased from 75.0 ± 31.2% to 7.5 ± 12.1% (SLA) and 
from 90.0 ± 12.9% to 30.0 ± 19.7% (TPS). Treatment success was found in 5 of the 
12 SLA (42%) and in 4 of the 14 TPS (29%).
Conclusions: The proposed reconstructive treatment, followed by SPT, was able to 
maintain in function the majority of SLA implants, although the overall treatment 
success was limited and many of TPS implants were removed. Therefore, the deci-
sion to treat implants affected by peri-implantitis should be based on several factors, 
including surface characteristics.
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estimated by several systematic reviews (Derks & Tomasi, 2015; 
Rakic et al., 2018) and large population cross-sectional studies 
(Dalago, Schuldt Filho, Rodrigues, Renvert, & Bianchini, 2017; 
Renvert, Lindahl, & Persson, 2018; Rokn et al., 2016; Schwarz, 
Becker, et al., 2017; Vignoletti, Di Domenico, Di Martino, 
Montero, & de Sanctis, 2019). The ideal aim of the treatment 
of peri-implantitis is the complete elimination of the peri-im-
plant infected tissues combined, if possible, to a reconstructive 
procedure to re-create an ideal seal around the osseointegrated 
implants. During the years, since the non-surgical treatment 
of peri-implantitis has been proved to be ineffective (Faggion, 
Listl, Frühauf, Chang, & Tu, 2014), several surgical approaches 
(Chan, Lin, Suárez, MacEachern, & Wang, 2014), some of which 
by means of regenerative materials (Khoury & Buchmann, 2001; 
Roos-Jansåker, Renvert, Lindahl, & Renvert, 2007; Schwarz, 
John, Mainusch, Sahm, & Becker, 2012), have been proposed 
with promising preliminary results (Khoshkam et al., 2013, 
2016).
The clinical positive outcomes of the surgical treatment have 
been advocated to the implant surface characteristics (Carcuac 
et al., 2016; Roccuzzo, Bonino, Bonino, & Dalmasso, 2011), while 
controversial results have been reported in respect of peri-im-
plant bony defect morphology (Roccuzzo, Gaudioso, Lungo, 
& Dalmasso, 2016; Schwarz, Sahm, Schwarz, & Becker, 2010). 
Regardless of the type of surgical approach, patients’ adhesion 
to a supportive peri-implant/ periodontal therapy (SPT) has been 
demonstrated to be fundamental for the positive long-term results 
(Heitz-Mayfield et al., 2018; Monje et al., 2016; Roccuzzo, Layton, 
Roccuzzo, & Heitz-Mayfield, 2018).
Despite the high-level of evidence of the long-term stability of 
the results obtained following periodontal regeneration (Cortellini, 
Buti, Pini Prato, & Tonetti, 2017; Roccuzzo, Marchese, Dalmasso, 
& Roccuzzo, 2018) with better long-term outcomes and less costs 
for re-intervention compared to access flap alone, only few studies 
assessed the long-term results of different peri-implant surgical pro-
cedures (Heitz-Mayfield et al., 2018; Roccuzzo, Pittoni, Roccuzzo, 
Charrier, & Dalmasso, 2017; Berglundh, Wennström, & Lindhe, 
2018; Bianchini et al., 2019; La Monaca, Pranno, Annibali, Cristalli, 
& Polimeni, 2018).
A previous publication (Roccuzzo et al., 2017) has reported posi-
tive results, after 7 years of SPT, of a surgical regenerative procedure 
on single crater-like peri-implantitis defects. Successful therapy, 
defined as PD ≤ 5 mm, absence of bleeding/suppuration on prob-
ing, and no further bone loss, was found in 14.3% of the TPS and in 
58.3% of the SLA implants.
Nevertheless, as indicated by the last EFP Workshop, the evi-
dence on the efficacy of the treatment of peri-implantitis defects 
by reconstructive procedures seems limited, especially in the long-
term (Tomasi, Regidor, Ortiz-Vigón, & Derks, 2019). In this regard, 
the aim of this study is to present the 10-year clinical and radio-
graphic outcomes in patients treated with a regenerative proce-
dure by means of a DBBMC and enrolled in an individually tailored 
SPT program.
2  | MATERIAL S AND METHODS
2.1 | Patient population
The original population consisted of 26 patients with one crater-
like defect, around either titanium plasma-sprayed surface (TPS) or 
sandblasted large grit and acid-etched surface (SLA) dental implants. 
Details of the treatment protocol have been described in previous 
publications reporting on the 1- and 7-year treatment outcomes 
(Roccuzzo et al., 2011; Roccuzzo et al., 2017). In brief, 26 patients 
(10 males and 16 females; mean age: 60 ± 7.9 years; four smokers), 
who presented a single peri-implantitis crater-like lesion with a PD 
of ≥6 mm and no implant mobility, were consecutively treated from 
those attending the principle investigator's private office (specialist 
periodontal practice, northwestern Italy) between January 2008–
June 2009. Exclusion criteria included the following:
1. PD < 6 mm;
2. Class II defects (characterized by consistent horizontal bone loss);
3. Multiple adjacent defects;
4. Implant mobility;
5. Hollow cylinders and hollow screws;
6. Implants placed by other clinicians;
7. Implants not properly positioned;
8. No interest in participating in the study.
Patients had been treated, in the previous years, for periodonti-
tis and subsequently were rehabilitated by means of dental implants 
(Straumann Dental Implant System; Straumann AG) of identical 
geometry and two different surfaces, either sandblasted and ac-
id-etched (SLA) or titanium plasma-sprayed (TPS). All implants sup-
ported cemented fixed dental prostheses. Patients had been placed 
on an individually tailored SPT, including continuous evaluation of 
the occurrence and the risk of disease progression. Patients had 
been recalled at various intervals, depending on the initial diagno-
sis and the results of the therapy, for motivation, reinstruction, in-
strumentation, and treatment, as needed. All patients had complied 
with the recall program until evaluation of the peri-implantitis. Only 
one implant defect per patient was included in the study (Table 1; 
Figure 1). Each patient was given a detailed description of the pro-
cedure. They were also informed that their data would be used for 
statistical analysis and gave their informed consent to the treatment. 
The prospective observational study was performed in accordance 
with the revised principles stated in the Declaration of Helsinki and 
the Good Clinical Practice Guidelines. The study protocol was ap-
proved by the Institutional Ethical Commitee (Nr.: 00188/2020).
2.2 | Surgical procedures and post-surgical care
All surgeries were performed by one surgeon (MR) with 25 year 
of experience in periodontal surgery. Following the elevation of a 
muco-periosteal flap, all granulation tissue was completely removed 
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from the defect area, and the implant surfaces covered with EDTA 
24% (PrefGel, Straumann AG) for 2 min and chlorhexidine 1% gel 
(Corsodyl dental gel, GlaxoSmithKline) for 2 min. Thereafter, the in-
trabony defects were filled with a deproteinized bovine bone mineral 
with 10% collagen (DBBMC) (Bio-Oss Collagen, Geistlich). In case of 
lack of keratinized tissue, a connective tissue graft was excised from 
the tuberosity area and applied to cover the entire defect to ensure 
stability of the graft material. Finally, the flap was sutured around 
the collar of the implant, with a thick cuff seal to ensure an optimal 
non-submerged healing.
Post-operative care included 1 g of amoxicillin and clavulanic 
acid twice a day for 6 days and 0.2% chlorhexidine digluconate 
rinse for 1 min three times a day for 3 weeks. After the heal-
ing phase, patients were placed on an individually tailored SPT 
program.
2.3 | Supportive peri-implant/periodontal therapy 
(SPT)
All patients underwent an individualized supportive care accord-
ing to their needs and risk profile, including oral hygiene measures, 
biofilm removal, monitoring oral health, and reduction in modifiable 
risks related to peri-implantitis. Every effort was made to motivate 
the patient and facilitate their ability to maintain plaque control 
both at implants and teeth, aiming for a low full mouth plaque score 





1 M 56 25 ø 4.1 × 10 mm TPS C Yes
2 F 53 31 ø 3.3 × 12 mm TPS C No
3 M 68 21 ø 4.1 × 10 mm SLA Yes
4 F 66 35 ø 4.1 × 10 mm TPS a  —
5 M 55 46 ø 4.1 × 08 mm SLA Yes
6 F 55 14 ø 4.1 × 10 mm TPS Yes
7 F 60 24 ø 4.1 × 10 mm SLA C No
8 M 68 27 ø 4.8 × 08 mm SLA a  —
9 F 67 26 ø 4.1 × 10 mm TPS D No
10 M 58 Yes 13 ø 4.1 × 10 mm SLA a  —
11 F 70 23 ø 4.1 × 08 mm TPS No
12 F 56 37 ø 4.8 × 08 mm SLA C No
13 F 79 35 ø 4.1 × 10 mm TPS a  —
14 M 60 26 ø 4.1 × 10 mm TPS a  —
15 F 54 26 ø 4.1 × 10 mm TPS C Yes
16 F 63 31 ø 4.1 × 10 mm TPS Yes
17 F 46 Yes 17 ø 4.8 × 10 mm SLA Yes
18 M 51 Yes 46 ø 4.1 × 12 mm TPS D No
19 F 71 17 ø 4.8 × 10 mm SLA Yes
20 M 64 Yes 35 ø 4.1 × 12 mm TPS Yes
21 F 57 36 ø 4.1 × 08 mm TPS Yes
22 F 56 27 ø 4.1 × 08 mm SLA Yes
23 F 56 14 ø 4.1 × 10 mm SLA Yes
24 F 63 46 ø 4.1 × 10 mm SLA Yes
25 M 45 36 ø 4.1 × 12 mm TPS D No
26 M 62 36 ø 4.8 × 10 mm SLA Yes
aPatient lost to follow-up. 
TA B L E  1   Data on patients, defect 
location, implant type, additional 
treatment, and implant survival
F I G U R E  1   Kaplan-Meier estimate of the survival rate of the 
implants as a function of the time since peri-implantitis surgical 
treatment
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(Heitz-Mayfield et al., 2018). If a patient could not to attend follow-
up examinations, he/she was classified as a “drop out.”
At signs of recurrence (increasing PD with concomitant BoP), local 
antibiotics and/or additional non-regenerative surgical therapy were 
performed, whenever needed, in order to treat further possible com-
plications and to facilitate proper oral hygiene procedure. During SPT, 
the cumulative interceptive supportive therapy (CIST; Mombelli & Lang, 
1998) was used. The number of sites treated according to therapy mo-
dality C (systemic antibiotic therapy or treatment with local delivery de-
vice) and D (antibiotics + surgery), during the 10 years, was registered.
2.4 | Clinical and radiographic examinations
At the 10-year examination, an examiner (SG) with more than 
15 years of experience as hygienist, blinded to the patients’ clas-
sification, recorded, for each test implant, PD measured at four 
sites (mesial, buccal, distal, and lingual) by means of a periodon-
tal probe (XP23/UNC 15; Hu-Friedy). At the same time and sites, 
the presence of dental plaque (Pl), of bleeding on probing (BOP), 
and of pus was recorded. Figures were rounded off to the nearest 
millimeter and compared with both the baseline and the 1- and 
7-year values.
Radiographically, the distance between the base of the im-
plant shoulder and the most coronal visible bone-to-implant con-
tact (BL) measured in millimeters, both at the mesial and the distal 
aspect of each implant, was collected using periapical intraoral 
films with a long cone technique (Bornstein, Schmid, Belser, Lussi, 
& Buser, 2005; Roccuzzo, Bunino, Prioglio, & Bianchi, 2001). Film 
holders, with no individualized bite blocks, were used. The base-
line and follow-up images were displayed on a computer monitor, 
and the changes of crestal bone was calculated by means of a 
commercially available software (ImageJ, U.S. National Institutes 
of Health), using the known implant's length for calibration. All 
radiological assessments were performed by one investigator 
(DP), blinded with respect to the implant surface.
The 10-year BL values were compared with the baseline, 
1- and 7-year values according to the technique previously de-
scribed by Roccuzzo et al. (2011) and Roccuzzo et al. (2017). 
Implants with both a 2.8 mm and a 1.8 mm smooth collar were 
analyzed, but the reference landmark was always the most cor-
onal level of the rough surface, which was originally at the level 
of the bone crest.
2.5 | Statistical analysis
Each patient contributed with one peri-implantitis lesion and was, 
therefore, considered as the statistical unit. The clinical param-
eters (PD, PI, BOP) were expressed as mean values or percentages 
at 4 sites ±SD, while the radiographic bone level values (BL) were 
calculated as mean at 2 sites (mesial and distal) ± SD. Finally, the 
presence or absence of suppuration was reported as a dichotomous 
variable. Only descriptive statistical analyses were performed due 
to the small sample size. To evaluate the implant survival rates of 
either TPS or SLA implants after reconstructive peri-implant sur-
gery, a Kaplan–Meier analysis (with log-rank pooled per strata) was 
performed.
3  | RESULTS
Supportive peri-implant therapy proceeded with no major complica-
tions in most patients. From the initial 26 patients included at base-
line, 14 (six TPS and eight SLA) reached the 10-year examination. 
Five patients (19%) were lost to follow-up. Reasons for drop out are 
listed in Table 2. During the 10-year examination, additional antibiotic 
and/or surgery was needed in eight patients (six TPS and two SLA). 
Patient demographics and implant characteristics are reported in 
Table 3. Excluding the drop outs, the overall implant survival rate at 
10-year was 55% for the TPS and 80% for the SLA implants, respec-
tively. Figure 2 illustrates the implants’ survival rate as a function of 
time from the surgical treatment of peri-implantitis. The clinical and 
radiographic parameters in both groups at baseline and at the 10-year 
follow-up are summarized in Table 4.
More in details, out of the implants still in function at 10 year, 
the overall PD decreased from 6.9 ± 1.3 to 3.7 ± 1.5 mm at 1 year, to 
3.2 ± 0.7 mm at 7 year and to 3.3 ± 0.5 at 10 year. In TPS group, PD 
decreased from 7.0 ± 1.4 to 4.5 ± 1.7 mm at 1 year, to 3.2 ± 0.7 mm 
at 7 year, and to 3.5 ± 0.5 at 10 year, while in SLA group, PD de-
creased from 6.8 ± 1.4 to 3.2 ± 1.0 mm at 1 year, to 3.1 ± 0.8 mm at 
7 year, and to 3.2 ± 0.5 at 10 year.
Through time, the overall BOP decreased from 82.1 ± 25.7% to 
28.5 ± 31.1% at 1 year, 14.3 ± 18.2% at 7 years, and 14.3 ± 18.2% 
at 10 year. In particular at baseline BOP was 92.0 ± 13% in TPS and 
75.0 ± 32.7% in SLA, at 1-year 54.2 ± 36.8% in TPS and 12.5 ± 13.4% 
in SLA, at 7-year 33.0 ± 20.4% in TPS and 6.3 ± 11.6% in SLA and at 
10-year 12.5 ± 21% in TPS and 12.5 ± 19% in SLA.
At baseline, plaque was detected around 59 ± 27% of all implants 
which reached the 10-year visit and decreased to 21.4 ± 19.2% at 
1 year, 5.4 ± 11% at 7 year, and to 7.1 ± 12% at 10 year. In detail, plaque 
was found around 75 ± 22.4% of TPS and 75 ± 32.7% of SLA implants. 
At 1-year examination, plaque was present around 25 ± 22.4% of TPS 
and 18.8 ± 17.7% of SLA. At 7-year examination, plaque was present 
around 8.3 ± 13% and 3.1 ± 8.8%, respectively. At 10-year examination, 
plaque was present around 4.2 ± 10.2% of TPS and 9.4 ± 13% of SLA.
The overall mean BL decreased from 3.2 ± 1.1 to 0.9 ± 1.0 mm. 
According to the type of implant, mean BL decreased from 3.4 ± 1.5 
to 1.4 ± 0.1 mm at 10-year around TPS implants and from 3.1 ± 0.9 
to 0.4 ± 0.6 mm at 10-year around SLA implants.
Before treatment, pus was present around ten of TPS and four of SLA 
implants. When considering only the 14 implants that reached the 10-
year analysis, pus was present at baseline around four of TPS and three of 
SLA implants. At the 10-year analysis, no implants presented suppuration.
Successful therapy, defined as PD ≤ 5 mm, absence of bleeding/
suppuration on probing, and no further bone loss, was found in four 
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of 14 (29%) of the TPS and in five of 12 (42%) of the SLA implants 
(Figure 3). Overall, nine out of 26 (35%) implants were successfully 
maintained for the entire observation period, while seven implants 
had to be removed (Table 5; Figure 4).
4  | DISCUSSION
The aim of the present study was to evaluate the long-term (10-
year) clinical and radiographic outcomes of a regenerative surgical 
procedure by means of DBBMC to treat peri-implantitis crater-like 
defects. This is, to the best of our knowledge, the first 10-year pro-
spective study that presents results on the influence of the surface 
characteristics on the long-term implant survival rate, after treat-
ment of peri-implantitis in a private clinic.
The present protocol was effective in BOP and PI reduction in 
both groups in the short (1-year) as well as in the long-term (7, 10-
year). Mean peri-implant pocket depths in both groups markedly 
decreased at the 1-year evaluation and remained stable during the 
following years of observation. Regarding interproximal bone lev-
els, it has to be underlined that both groups experienced a signifi-
cant improvement 1-year after treatment, while a slight tendency 
to relapse around the TPS surfaces was detected at the 7- and 10-
year analysis. During the 10-year examination, five implants with a 
TPS surface (35.7%) and two implants with an SLA surface (16.6%) 
had to be removed due to recurrent infections. Treatment success 
(PD ≤ 5 mm, absence of bleeding/suppuration on probing, and no 
further bone loss) was obtained in four of 14 (29%) of the TPS and in 
five of 12 (42%) of the SLA implants. These results confirm the short-
term findings that surface characteristics may have an impact on the 
surgical regenerative treatment of peri-implantitis defects.
The key role of implant surface on re-osseointegration has been 
investigated in animal studies, with controversial results (Albouy, 
Abrahamsson, Persson, & Berglundh, 2011; Almohandes, Carcuac, 
Abrahamsson, Lund, & Berglundh, 2019; Carcuac, Abrahamsson, 
Charalampakis, & Berglundh, 2015; Persson, Berglundh, Sennerby, & 
Lindhe, 2001). However, an interesting recent case report suggested 
this possibility in a clinical human scenario (Fletcher et al., 2017).
In a long-term retrospective study up to 11-year, Berglundh 
et al., 2018, reported better clinical outcomes in term of PPD and BOP 
reduction at implants with non-modified surfaces than at those with 
a modified surface. These results confirmed those previously pub-
lished by the same group in a 1- and 3-year RCT (Carcuac et al., 2016, 
TA B L E  2   List of reasons for drop out
n
Death 3
Severe health problems 1
Moved 0
Refused to accept a visit 1
Total 5
TA B L E  3   Parameters for TPS (n = 14) and in SLA (n = 12) 
implants
TPS SLA
Implants at baseline 14 12
Drop out 3 2
CIST C/Da  6 2
Implant lost 5 2
Treatment successb  4 (29%) 5 (42%)
aSites treated according to modalities C and D of CIST (antibiotics and/
or surgery). 
bNo further bone loss, no pus, PD ≤ 5 mm, and BOP = 0, at 10 years. 
F I G U R E  2   Success rate within the TPS and SLA implant surfaces through time
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2017) pointing out how the implant surface had a role on the treat-
ment outcomes. One of the major differences between the surgical 
procedures used in these studies and the present proposal protocol 
is the use of an access flap, aimed to pocket elimination compared to 
a regenerative approach aimed to reconstruct the intrabony compo-
nent of the peri-implant defects. Due to this main difference, com-
parisons among studies seem difficult. Moreover, it should be noted 
that the study by Carcuac et al. (2017) was not specifically designed 
to evaluate the impact of implant surface characteristics on treatment 
outcomes, as underlined by the uneven distribution between modi-
fied and non-modified implants. Therefore, the results referred to the 
category “modified,” which included different surface modifications, 
should be therefore interpreted with great caution.
Recently, long-term studies with at least 3 years of follow-up 
evaluating different regenerative protocols to treat peri-implant 
defects have been published (Andersen, Aass, & Wohlfahrt, 2017; 
Isehed, Svenson, Lundberg, & Holmlund, 2018; La Monaca 
et al., 2018; Mercado, Hamlet, & Ivanovski, 2018; Roos-Jansåker, 
Persson, Lindahl, & Renvert, 2014; Schwarz, John, Schmucker, Sahm, 
& Becker, 2017): Roos-Jånsaker investigated, in a 5-year RCT, the 
adjunctive use of a resorbable membrane with or without a bone fill 
F I G U R E  3   Mandibular right implant, showing excessive probing 
depth, bleeding and pus, shortly before surgical treatment
TA B L E  5   Success rates expressed in number and percentages at 
1, 7 and 10-year follow-up after treatment and SPT
N = 26
1 year 7 years 10 years
n % n % n %
Success 8 31 9 35 9 35
Partial resolution 18 69 11 42 5 19
Lost to follow-up 0 0 2 8 5 19
Implant loss 0 0 4 15 7 27
Baseline 1-year 7-year 10-year
PD (mm)
Overall 6.9 ± 1.3 3.7 ± 1.5 3.2 ± 0.7 3.3 ± 0.5
SLA 6.8 ± 1.4 3.2 ± 1.0 3.1 ± 0.8 3.2 ± 0.5
TPS 7.0 ± 1.4 4.5 ± 1.7 3.2 ± 0.7 3.5 ± 0.5
Deepest PD (mm)
Overall 8.2 ± 1.3 4.6. ± 1.9 3.9 ± 0.8 4.1 ± 0.8
SLA 8.0 ± 1.3 3.5 ± 1.2 3.8 ± 0.7 4.1 ± 0.8
TPS 8.5 ± 1.4 5.7 ± 2.1 4.0 ± 0.9 4.2 ± 0.8
Bone level (mm)
Overall 3.2 ± 1.1 1.3 ± 0.9 0.9 ± 0.8 0.9 ± 1
SLA 3.1 ± 0.9 1.6 ± 0.8 0.5 ± 0.6 0.4 ± 0.6
TPS 3.4 ± 1.5 1.8 ± 0.1 1.4 ± 0.2 1.4 ± 0.1
BOP at the implant site (%)
Overall 82.1 ± 25.7 28.5 ± 31.1 14.3 ± 18.2 14.3 ± 18.2
SLA 75 ± 32.7 12.5 ± 13.4 6.3 ± 11.6 12.5 ± 19
TPS 92 ± 13 54.2 ± 36.8 33.3 ± 20.4 12.5 ± 21
Pl at the implant site (%)
Overall 59 ± 27 21.4 ± 19.2 5.4 ± 11 7.1 ± 12
SLA 75 ± 32.7 18.8 ± 17.7 3.1 ± 8.8 9.4 ± 13
TPS 75 ± 22.4 25 ± 22.4 8.3 ± 13 4.2 ± 10.2
Pus
Overall 7 (50%) 1 (21%) 0 (0%) 0 (0%)
SLA 3 (20%) 0 (0%) 0 (0%) 0 (0%)
TPS 4 (30%) 1 (21%) 0 (0%) 0 (0%)
TA B L E  4   Clinical parameters around 
the eight SLA and six TPS implants, 
which reached the 10-year examination 
(means ± SD)
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to treat peri-implantitis intrabony defects. The obtained data failed 
to suggest its clinical use since comparable results in terms of radio-
graphic bone fill were detected.
The 7-year results on 15 patients treated with a combined re-
sective and regenerative approach reported by Schwarz, Becker, 
et al., 2017 showed clinical stable parameters in term of PD and BOP 
reduction, even though no data on the radiographic measurements 
were provided.
More recently, long-term (7-year) data on alternative regen-
erative materials (i.e., porous titanium granules) to successfully 
treat peri-implantitis defect have been published by Andersen 
et al., 2017: Around the 12 patients available for analysis, radio-
graphic defect depth changes were comparable to the 1-year 
results with no difference when compared OFD group. Similar 
results have been published by Isehed et al., 2018, who investi-
gated the efficacy of EMD to treat peri-implantitis: At the 5-year 
follow-up, only 14 patients were considered for analysis which did 
not revealed any statistically significant difference between test 
(OFD + EMD) and control (OFD).
A tendency to relapse after more years of observation following 
regenerative procedures to manage peri-implant defects has been 
also recently reported by La Monaca et al., 2018: In particular the 
percentage of implants successfully treated at 1-year 91% dropped 
down to 59% at the 5-year evaluation, underlining the difficulties in 
maintaining the promising short-term results.
Following these findings, the question of which regenerative ma-
terial should be considered ideal is still open. In the present study, 
DBBMC was preferred to DBBM alone due to the better handling mo-
dality and the possibility to be used with no membrane. The positive 
results seem corroborated by a 3-year prospective study (Mercado 
et al., 2018) where similar clinical results (i.e., PD and BOP reduction) 
after a regenerative approach with the same bone substitute were 
found. However, it has to be underlined that the wide difference in fol-
low-up periods (10- vs. 3-year), the use of different clinical thresholds 
to define “treatment success,” as well as the adjunctive use of EMD 
and a locally delivered antibiotic, make precise comparison difficult.
Irrespective of the surgical approach, the adhesion to an ade-
quate maintenance care program has been shown to be crucial to 
preserve the obtained results in the long-term. A recent systematic 
review by Roccuzzo et al. (2018), based on 13 publications with a 
follow-up of at least 3 years, reported the favorable results in term 
of implant survival rate after therapy of peri-implantitis followed by 
regular supportive care. Nonetheless, due to the high heterogeneity 
between studies in terms of frequency and protocols applied during 
SPT, no clear clinical recommendations could be indicated. More re-
cently, a tool for preventing peri-implant disease, based on the as-
sessment of various risks, was presented. The tool could also help 
clinicians to optimize the maintenance care of patients after they re-
ceived treatment of peri-implantitis defects (Heitz-Mayfield, Heitz, 
& Lang, 2020).
This study presents several limitations: First, and most import-
ant, the sample size is very small. Secondly, the number of drop 
outs is high, even though it is in the same percentage range of 
other similar long-term publications (Heitz-Mayfield et al., 2018; 
Schwarz, Becker, et al., 2017). Third, the clinical and the radio-
graphic measurements did not follow a calibration session, even 
though they were all collected by experienced dental profession-
als, blinded to the type of implants. For these reasons, data anal-
ysis did not allow generalizability to a population-based setting 
through a statistical analysis. Finally, a precise assessment of the 
quality of supportive therapy, during the entire long observation 
period, was not possible, even though most patients were seen 
on average three to four times a year, in accordance with similar 
recent studies (Carcuac et al., 2017; Heitz-Mayfield et al., 2018; 
Isehed et al., 2018).
Within the limitations above described, the proposed regen-
erative surgical approach, followed by an adequate SPT protocol, 
resulted in stable clinical parameters during the 10-year period ex-
amination, around most of the SLA implants. Indeed, it has to be 
underlined that most TPS implants were lost, while a significant 
number of both implants required adjunctive treatment.
In conclusion, it can be suggested that the decision on whether 
to treat or remove an implant should be based on several factors, 
thoroughly discussed with the patient, including implant surface 
characteristics.
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